Elderly lung CA patients benefit from aggressive chemo‘Remarkable’ four-month improvement in survival will change practice, researchers say Selenium a bust in lung cancerSupplement fails to prevent secondary tumour development Sponge-derived drug extends breast CA survival Eribulin among ‘handful’ of effective agents for metastatic disease Many NPs lack oncology expertise: study Supervising physicians act as educators for NPs new to oncology. Yondelis approved for relapsed ovarian cancer New drug delivery system: the nanosponge? Elderly lung cancer patients benefit from aggressive chemo 'Remarkable' four-month improvement in survival will change practice, researchers say Sponge-derived drug extends breast cancer survival Radiation-hormone therapy combo best for high-risk prostate cancer Breast density decrease linked with lower cancer risk First Previous 69 70 71 72 73 Next Last
